
|Articles|May 27, 2020
ASCRS 2020: Evaluation of intraoperative use of DEXYCU on signs/symptoms of dry eye
Author(s)Alex Delaney-Gesing
Advertisement
Sanjay N. Rao, MD, director of Refractive, Cornea and Advanced Anterior Segment Surgery at Dekalb Eye Consultants LLC, speaks with Ophthalmology Times' David Hutton on his presentation "Evaluation of intraoperative use of dexamethasone intraocular suspension, 9% (DEXYCU) on signs and symptoms of dry eye," during the 2020 ASCRS virtual conference.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision
2
AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives
3
Managing Unique Dry Eye Disease Subtypes in Patients
4
AGC Biologics to manufacture AAVantgarde’s dual-vector gene therapies, AVB-039 and AAVB-081
5

















































.png)


